annual EBITDA:
-$212.51M+$385.79M(+64.48%)Summary
- As of today (May 29, 2025), SMMT annual EBITDA is -$212.51 million, with the most recent change of +$385.79 million (+64.48%) on December 31, 2024.
- During the last 3 years, SMMT annual EBITDA has fallen by -$126.61 million (-147.38%).
- SMMT annual EBITDA is now -1923.36% below its all-time high of $11.65 million, reached on January 31, 2019.
Performance
SMMT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$62.89M-$1.74M(-2.85%)Summary
- As of today (May 29, 2025), SMMT quarterly EBITDA is -$62.89 million, with the most recent change of -$1.74 million (-2.85%) on March 31, 2025.
- Over the past year, SMMT quarterly EBITDA has dropped by -$22.56 million (-55.95%).
- SMMT quarterly EBITDA is now -273.30% below its all-time high of $36.29 million, reached on July 31, 2018.
Performance
SMMT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$235.07M-$22.56M(-10.62%)Summary
- As of today (May 29, 2025), SMMT TTM EBITDA is -$235.07 million, with the most recent change of -$22.56 million (-10.62%) on March 31, 2025.
- Over the past year, SMMT TTM EBITDA has dropped by -$130.41 million (-124.59%).
- SMMT TTM EBITDA is now -1675.25% below its all-time high of $14.92 million, reached on April 1, 2019.
Performance
SMMT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SMMT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.5% | -56.0% | -124.6% |
| 3 y3 years | -147.4% | -204.8% | -162.5% |
| 5 y5 years | -682.4% | -607.4% | -825.4% |
SMMT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -177.5% | +64.5% | -417.3% | +88.2% | -224.4% | +60.7% |
| 5 y | 5-year | -682.4% | +64.5% | -607.4% | +88.2% | -825.4% | +60.7% |
| alltime | all time | -1923.4% | +64.5% | -273.3% | +88.2% | -1675.3% | +60.7% |
SMMT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$62.89M(+2.9%) | -$235.07M(+10.6%) |
| Dec 2024 | -$212.51M(-64.5%) | -$61.15M(+13.7%) | -$212.51M(+14.8%) |
| Sep 2024 | - | -$53.78M(-6.1%) | -$185.04M(+23.5%) |
| Jun 2024 | - | -$57.26M(+42.0%) | -$149.78M(+43.1%) |
| Mar 2024 | - | -$40.33M(+19.7%) | -$104.67M(-82.5%) |
| Dec 2023 | -$598.30M(+681.3%) | -$33.67M(+81.9%) | -$598.30M(+3.0%) |
| Sep 2023 | - | -$18.51M(+52.3%) | -$580.95M(-0.3%) |
| Jun 2023 | - | -$12.16M(-97.7%) | -$582.42M(-0.6%) |
| Mar 2023 | - | -$533.96M(+3170.8%) | -$585.79M(+708.4%) |
| Dec 2022 | -$76.58M(-10.9%) | -$16.32M(-18.3%) | -$72.46M(-12.2%) |
| Sep 2022 | - | -$19.98M(+28.7%) | -$82.57M(+1.2%) |
| Jun 2022 | - | -$15.53M(-24.7%) | -$81.55M(-8.9%) |
| Mar 2022 | - | -$20.63M(-21.9%) | -$89.56M(+4.9%) |
| Dec 2021 | -$85.91M(+69.6%) | -$26.43M(+39.3%) | -$85.37M(+21.7%) |
| Sep 2021 | - | -$18.97M(-19.4%) | -$70.16M(+5.0%) |
| Jun 2021 | - | -$23.54M(+43.2%) | -$66.81M(+14.8%) |
| Mar 2021 | - | -$16.44M(+46.5%) | -$58.20M(+14.9%) |
| Dec 2020 | -$50.65M(+86.5%) | - | - |
| Dec 2020 | - | -$11.22M(-28.2%) | -$50.65M(+28.5%) |
| Sep 2020 | - | -$15.62M(+4.7%) | -$39.43M(+18.7%) |
| Jun 2020 | - | -$14.92M(+67.9%) | -$33.23M(+30.8%) |
| Mar 2020 | - | -$8.89M(-5.6%) | -$25.40M(-3.9%) |
| Dec 2019 | -$27.16M(-333.1%) | - | - |
| Oct 2019 | - | -$9.42M(+32.8%) | -$26.43M(-7.1%) |
| Jul 2019 | - | -$7.09M(+23.1%) | -$28.46M(-290.7%) |
| Apr 2019 | - | -$5.76M(+38.6%) | $14.92M(+23.1%) |
| Jan 2019 | $11.65M(-136.2%) | - | - |
| Jan 2019 | - | -$4.16M(-63.7%) | $12.12M(>+9900.0%) |
| Oct 2018 | - | -$11.45M(-131.5%) | $69.30K(-99.2%) |
| Jul 2018 | - | $36.29M(-523.7%) | $8.77M(-126.4%) |
| Apr 2018 | - | -$8.56M | -$33.18M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | -$32.19M(+3.9%) | - | - |
| Jan 2018 | - | -$16.21M(+491.0%) | -$32.00M(+33.7%) |
| Oct 2017 | - | -$2.74M(-51.6%) | -$23.93M(-13.4%) |
| Jul 2017 | - | -$5.66M(-23.4%) | -$27.62M(-12.5%) |
| Apr 2017 | - | -$7.39M(-9.2%) | -$31.58M(-4.9%) |
| Jan 2017 | -$30.98M(+7.2%) | - | - |
| Jan 2017 | - | -$8.14M(+26.4%) | -$33.20M(+3.2%) |
| Oct 2016 | - | -$6.43M(-33.1%) | -$32.18M(-5.8%) |
| Jul 2016 | - | -$9.62M(+6.8%) | -$34.17M(+6.7%) |
| Apr 2016 | - | -$9.01M(+26.5%) | -$32.02M(+11.0%) |
| Jan 2016 | -$28.91M(+57.9%) | - | - |
| Jan 2016 | - | -$7.12M(-15.4%) | -$28.86M(+13.6%) |
| Oct 2015 | - | -$8.42M(+12.7%) | -$25.40M(+18.6%) |
| Jul 2015 | - | -$7.47M(+27.8%) | -$21.41M(+7.2%) |
| Apr 2015 | - | -$5.84M(+59.2%) | -$19.98M(+5.9%) |
| Jan 2015 | -$18.30M(+66.1%) | - | - |
| Jan 2015 | - | -$3.67M(-17.1%) | -$18.86M(-2.5%) |
| Oct 2014 | - | -$4.43M(-26.6%) | -$19.35M(+6.5%) |
| Jul 2014 | - | -$6.04M(+27.6%) | -$18.17M(+49.7%) |
| Apr 2014 | - | -$4.73M(+13.8%) | -$12.14M(+63.9%) |
| Jan 2014 | -$11.02M(+55.8%) | - | - |
| Jan 2014 | - | -$4.16M(+28.1%) | -$7.40M(+128.1%) |
| Oct 2013 | - | -$3.25M | -$3.25M |
| Jan 2013 | -$7.07M(+60.5%) | - | - |
| Jan 2012 | -$4.41M(-49.0%) | - | - |
| Jan 2011 | -$8.65M(+59.9%) | - | - |
| Jan 2010 | -$5.41M(-66.3%) | - | - |
| Jan 2009 | -$16.03M(-13.8%) | - | - |
| Jan 2008 | -$18.58M(+203.0%) | - | - |
| Jan 2007 | -$6.13M(+106.4%) | - | - |
| Jan 2006 | -$2.97M(+463.8%) | - | - |
| Jan 2005 | -$527.20K | - | - |
FAQ
- What is Summit Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Summit Therapeutics?
- What is Summit Therapeutics annual EBITDA year-on-year change?
- What is Summit Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Summit Therapeutics?
- What is Summit Therapeutics quarterly EBITDA year-on-year change?
- What is Summit Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Summit Therapeutics?
- What is Summit Therapeutics TTM EBITDA year-on-year change?
What is Summit Therapeutics annual EBITDA?
The current annual EBITDA of SMMT is -$212.51M
What is the all time high annual EBITDA for Summit Therapeutics?
Summit Therapeutics all-time high annual EBITDA is $11.65M
What is Summit Therapeutics annual EBITDA year-on-year change?
Over the past year, SMMT annual EBITDA has changed by +$385.79M (+64.48%)
What is Summit Therapeutics quarterly EBITDA?
The current quarterly EBITDA of SMMT is -$62.89M
What is the all time high quarterly EBITDA for Summit Therapeutics?
Summit Therapeutics all-time high quarterly EBITDA is $36.29M
What is Summit Therapeutics quarterly EBITDA year-on-year change?
Over the past year, SMMT quarterly EBITDA has changed by -$22.56M (-55.95%)
What is Summit Therapeutics TTM EBITDA?
The current TTM EBITDA of SMMT is -$235.07M
What is the all time high TTM EBITDA for Summit Therapeutics?
Summit Therapeutics all-time high TTM EBITDA is $14.92M
What is Summit Therapeutics TTM EBITDA year-on-year change?
Over the past year, SMMT TTM EBITDA has changed by -$130.41M (-124.59%)